On March 25th, the National Medical Products Administration and the National Health Commission issued the "Announcement on the Issuance of the 2025 Edition of the Pharmacopoeia of the People's Republic of China (No. 29 of 2025)" and declared that it would come into effect on October 1st, 2025!

The 2025 edition of the Chinese Pharmacopoeia officially includes drug packaging material testing in the mandatory standard system, and puts forward higher requirements for indicators such as sealing, mechanical properties, and chemical compatibility of drug packaging. Jinan Ruilaibo Intelligent Technology Co., Ltd., as an industry leading enterprise, deeply focuses on the pain points of pharmaceutical companies and has launched a full range of intelligent drug packaging material testing equipment. With precise testing technology and intelligent management systems, it helps enterprises achieve full process compliance in production.

1.1 Industry Opportunities and Challenges under the Background of Pharmacopoeia Upgrade

The new version of the pharmacopoeia specifies that drug packaging materials must comply with YBB standards and GMP appendix requirements, and quantitative limits are added to key indicators such as ampoule breaking force, glass bottle internal pressure resistance, and packaging sealing. This transformation is like a major industry test, bringing opportunities and challenges to pharmaceutical companies. On the one hand, strict standards encourage pharmaceutical companies to pay more attention to the quality of drug packaging, driving the entire industry towards higher quality development; On the other hand, pharmaceutical companies need to quickly adjust their production and testing processes to meet the new regulations, which is undoubtedly a daunting task.

In this context, Ruilai Platinum has a keen market insight and proactively laid out research and development. The R&D team conducted in-depth research on every requirement of the new version of the pharmacopoeia, analyzed the possible problems of different drug packaging materials under the new regulations, optimized and upgraded the equipment in advance, ensured seamless connection between equipment performance and the new pharmacopoeia regulations, and provided timely and powerful support for pharmaceutical companies.

1.2 Ruilai Platinum Intelligent Technology: Innovative Intelligent Detection

Based on more than 10 years of technological accumulation, Ruilai Platinum has built a full chain solution covering sealing testing, mechanical performance testing, and container integrity evaluation. The company has a team composed of senior R&D experts and technical elites who constantly explore new technologies and methods, integrating advanced sensor technology, automation control technology, and data analysis technology into products, so that the products can not only meet current testing needs, but also have good scalability and foresight.

Ruilai Platinum's product matrix is rich and diverse, including star equipment such as FFY-06 sealing tester, AZY-03 breaking force tester, CZD-80 circular jumping tester, etc., fully covering mainstream drug packaging materials such as injection bottles, penicillin bottles, and composite film bags. These devices are designed with full consideration of users' operating habits and practical needs, and have the advantages of easy operation, precise testing, and strong stability, which can help pharmaceutical companies efficiently complete drug packaging material testing work.